TABLE 1.

Baseline Characteristics of the Study Population

	Placebo (n=7)	Ezetimibe 10 mg/d (n=30)
Age, y
Mean	37.6	37.0
Range	13–57	9–72
Age subgroup, n (%)
<18 y	1 (14)	4 (13)
≥18 y	6 (86)	26 (87)
Gender, n (%)
Female	6 (86)	18 (60)
Male	1 (14)	12 (40)
Race, n (%)
White	6 (86)	27 (90)
Asian	0 (0)	1 (3)
Hispanic	1 (14)	2 (7)
Body weight, kg
Mean	63.0	67.5
Range	38.9–90.5	37.2–103.6
Time since diagnosis, y
Mean	15.4	15.0
Range	6–32	0–32
Prior treatment of sitosterolemia, n (%)
None	0 (0)	10 (33)
Statins	2 (29)	8 (27)
Bile salt-binding resins	4 (57)	11 (37)
Ileal bypass surgery	2 (29)	3 (10)
Apheresis	0 (0)	1 (3)